US Patent Issued to Incyte on Oct. 14 for "Naphthyridine compounds as inhibitors of KRAS" (Delaware, New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,742, issued on Oct. 14, was assigned to Incyte Corp. (Wilmington, Del.).

"Naphthyridine compounds as inhibitors of KRAS" was invented by Gencheng Li (Claymont, Del.), Haolin Yin (Wilmington, Del.), Chao Qi (Wilmington, Del.), Xiaozhao Wang (Mt. Laurel, N.J.), Wenqing Yao (Wilmington, Del.), Bin Hu (Garnet Valley, Pa.) and Peter Carlsen (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated...